Please assess the completion status of the following clinical trial:

Trial Title: Diet as a Potential Treatment for Autosomal Dominant Polycystic Kidney Disease

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Adults 18 to 60 years of age, who have ADPKD with an estimated glomerular filtration rate (eGFR) of 60 ml/min/1.73m2 or above~Exclusion Criteria:~1. Patients on chronic use of medications known to affect AVP secretion (Serotonin Specific Reuptake inhibitors (SSRI), Opioids, Tricyclic Antidepressants (TCA) and Tolvaptan)~2. History of diseases influencing renal concentration capacity, such as, diabetes insipidus, adrenal or thyroid deficiencies, present or prior use of lithium, or kidney diseases other than ADPKD.~3. Baseline hyponatremia (Na below 135 mEq/l)~4. Inability to comply with dietary or fluid requirements~5. Have physical or cognitive impairments which prevent participation~6. Pregnant women

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: f

Study Arms:
- Diet and Water adjustment (Type: ACTIVE_COMPARATOR): Reduction in dietary salt and protein intake
- Control (Type: NO_INTERVENTION): Continue with usual diet

Based on this trial design, predict the completion outcome and termination type (if applicable).